Boehringer Ingelheim (China)

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.2K citations · Full text

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

Yi‐Long Wu, Caicun Zhou, Chengping Hu et al. · The Lancet Oncology · 2014 · 2K citations

Lux-lung 6, Medicine, Randomised Phase 3 +8

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.5K citations · Full text

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Hans‐Christoph Diener, Ralph L. Sacco, J. Donald Easton et al. · New England Journal of Medicine · 2019 · 788 citations · Full text

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

Hans‐Christoph Diener, Ralph L. Sacco, Salim Yusuf et al. · The Lancet Neurology · 2008 · 353 citations · Full text

Thrombosis, Cardiovascular Disease, Ischemic Stroke +15